Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma

24 Mar 2016

Abstract excerpt

IMPORTANCE: There are well-documented racial disparities in outcomes for African American patients with clear cell renal cell carcinoma (ccRCC). Despite a dramatic improvement in overall survival in white patients since the advent of targeted therapy, survival for African Americans with advanced ccRCC has not changed. There is little known about potential racial differences in tumor biology of ccRCC. OBJECTIVE:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27010573
DOI: 10.1001/jamaoncol.2016.0005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell CarcinomaPMID 27010573Read ↗

Molecular genetics of clear-cell renal cell carcinoma.Semantic proximity Read ↗

Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney CarcinomaSemantic proximity Read ↗

Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.Semantic proximity Read ↗

Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma.Semantic proximity Read ↗

Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.Semantic proximity Read ↗

Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.Semantic proximity Read ↗

APOBEC family reshapes the immune microenvironment and therapy sensitivity in clear cell renal cell carcinoma.Semantic proximity Read ↗

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.Semantic proximity Read ↗

Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors.Semantic proximity Read ↗

Genomic ancestry in kidney cancer: Correlations with clinical and molecular featuresSemantic proximity Read ↗

Investigating racial disparities in carcinomas through TCGA transcriptomic and proteomic databaseSemantic proximity Read ↗

A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.